Metabolic brain diseaseHumansOxytocinIschemic StrokeAnimalsNeuroprotective Agents
Oxytocin-mediated neuroprotection in ischemic stroke: molecular mechanisms, therapeutic potential and clinical translational prospects.
Yuan Chen, Tao Li, Long Zou, Yanhui Li
Published: 202510.1007/s11011-025-01754-z
Abstract
Ischemic stroke (IS), also known as ischemic cerebrovascular accident, is a serious consequence of cerebral ischemia characterized by high morbidity, disability, and mortality. The primary causes of IS include atherosclerosis, cardiogenic embolism, l…
Preview only. Read the full abstract at the source